Target up and up Salicylic Acid Acne Wash

Description

The product is identified by SPL code 34089-3. It is presented as a white to off-white, round, biconvex tablet, imprinted with "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. The formulation includes inactive ingredients such as lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, and magnesium stearate.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic or nonteratogenic effects mentioned associated with the use of this drug.

Dosage and Administration

The affected area should be covered with a thin layer of the medication and rinsed thoroughly. The recommended frequency of application is one to three times daily. In cases where bothersome dryness or peeling occurs, the application frequency should be reduced to once daily or every other day.

To minimize the risk of excessive drying of the skin, it is advisable to initiate treatment with one application daily. Based on the patient's response and as directed by a healthcare professional, the frequency may be gradually increased to two or three times daily if necessary.

Contraindications

Use of this product is contraindicated in patients with a history of eye contact. In the event of contact with the eyes, it is imperative to flush thoroughly with water to mitigate potential irritation or injury. No other contraindications have been identified.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to seek emergency medical assistance immediately if the product is ingested, or to contact a Poison Control Center without delay.

It is important to note that the concurrent use of this product with other topical acne medications may increase the risk of skin irritation and dryness. Therefore, if patients experience any signs of irritation, they should be instructed to limit their use to one topical acne medication at a time.

Healthcare providers should also emphasize the necessity of avoiding contact with the eyes. In the event of accidental contact, patients should be advised to flush the eyes thoroughly with water to mitigate any potential adverse effects.

No specific laboratory tests are recommended for monitoring the use of this product.

Side Effects

Patients should be aware that the product is intended for external use only. This warning is critical to ensure safe and effective use, as improper application may lead to adverse reactions.

In clinical trials and postmarketing experiences, no specific adverse reactions were reported; however, the importance of adhering to the external use directive cannot be overstated. Participants are advised to follow the instructions provided to minimize the risk of potential side effects associated with inappropriate use.

Drug Interactions

Concurrent use of topical acne medications may increase the risk of skin irritation and dryness. It is advisable to limit the use of topical acne treatments to one at a time to minimize the potential for adverse effects. If irritation occurs, the patient should discontinue the use of additional topical acne medications and consult a healthcare professional for further guidance.

Packaging & NDC

Below are the non-prescription pack sizes of Target up and up Salicylic Acid Acne Wash (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of Target Up and Up Salicylic Acid Acne Wash in geriatric patients. The prescribing information does not provide guidance on dosage adjustments, safety concerns, or special precautions for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when recommending this product to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment efficacy and safety in this population.

Pregnancy

The safety of salicylic acid during pregnancy has not been established. Salicylic acid is contraindicated in pregnancy due to potential risks to the fetus, including the risk of teratogenic effects associated with its use. Therefore, pregnant women should avoid using products containing salicylic acid to mitigate any potential harm to fetal outcomes. Healthcare professionals are advised to counsel women of childbearing potential regarding these risks and to recommend alternative treatments that are deemed safer during pregnancy.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific concerns have been identified in the available information.

Renal Impairment

There is no specific information regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution when administering the medication. It is essential to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, immediate medical attention should be sought. Healthcare providers should implement supportive measures as necessary, which may include symptomatic treatment and monitoring of vital signs.

Due to the lack of detailed overdosage information, it is recommended that healthcare professionals refer to established clinical guidelines and protocols for managing overdose situations relevant to the specific medication in question. Additionally, contacting a poison control center may provide further guidance on appropriate management strategies.

Continued vigilance and patient assessment are crucial in mitigating potential risks associated with overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of swallowing the medication, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed that the use of this medication may lead to skin irritation and dryness, particularly if they are using another topical acne medication concurrently. It is recommended that patients use only one topical acne medication at a time to minimize the risk of irritation.

Additionally, healthcare providers should instruct patients to avoid contact with the eyes. If contact occurs, patients should be advised to flush the eyes thoroughly with water to mitigate any potential irritation.

Storage and Handling

The product is supplied in configurations that may include various packaging options. It is important to note that the product has the potential to stain certain fabrics, and appropriate precautions should be taken during handling to avoid contact with such materials.

For optimal storage, the product should be maintained at controlled room temperature. Specific temperature ranges and container requirements are not provided; however, it is advisable to store the product in a cool, dry place, away from direct sunlight and moisture. Special handling needs should be observed to prevent any accidental staining or damage to surfaces.

Additional Clinical Information

The medication is administered topically, with a recommended application of a thin layer covering the entire affected area. Patients should rinse thoroughly one to three times daily. In cases of bothersome dryness or peeling, the frequency of application should be reduced to once a day or every other day. It is advised to start with one application daily and gradually increase to two or three times daily as needed or as directed by a healthcare professional.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Target up and up Salicylic Acid Acne Wash, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)